Cancer News and Research

Latest Cancer News and Research

New data on pixantrone Phase III trial in non-Hodgkin's lymphoma to be presented

Cell Therapeutics, Inc. (CTI) announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present new data on the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL) at the 51st Annual Meeting of the American Society of Hematology on Saturday, December 5, 2009 in New Orleans, Louisiana.

2 Dec 2009

TGF--1 suppresses the growth of cancer cells, find researchers

UT Southwestern Medical Center researchers have found that a naturally occurring protein -- transforming growth factor beta1 (TGF--1) -- which normally suppresses the growth of cancer cells, causes a rebound effect after a prolonged exposure.

2 Dec 2009

Cancer Genomic Microarray Facility selects febit's Geniom RT Analyzer to advance its biomedical research

The Cancer Genomic Microarray Facility at the Kimmel Cancer Center of the Thomas Jefferson University, Philadelphia, selected febit's Geniom® RT Analyzer to advance its biomedical research by proceeding targeted Next-Generation Sequencing (NGS), genome-wide single nucleotide polymorphism (SNP) and microRNA (miRNA) analysis.

2 Dec 2009

RapidArc radiotherapy technology delivers highly-precise IMRT treatment

Former New Jersey Assemblyman Francis Bodine was surprised and delighted when his radiotherapy treatment sessions for prostate cancer went from about 20 minutes each day to less than five.

2 Dec 2009

Fight 2 Win PSA launched to find a cure for Hodgkin's Disease

Leading post-production house Optimus Santa Monica today announced that the “Fight 2 Win” PSA – created by Draftfcb Irvine Creative Director Scott Murray, produced by Draftfcb Irvine Senior Producer Tom Anderson, directed by RSA’s Russo Brothers and edited by Optimus Santa Monica Editor Hovig Menakian– has launched and will run through the end of 2009 on Fox, Turner and ESPN.

2 Dec 2009

Results from ongoing clinical trial of ISF35 to be presented at ASH annual meeting

Memgen announced today that results from its ongoing, Leukemia & Lymphoma Society co-sponsored clinical trial in chronic lymphocytic leukemia (CLL) have been selected for an oral presentation at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.

2 Dec 2009

Targeted breast ultrasound: A safe and cost effective alternative for women under 40

Targeted breast ultrasound of suspicious areas of the breast, including lumps, is a safe, reliable and cost-effective alternative to invasive biopsies for women under age 40, according to the findings of two studies presented today at the annual meeting of the Radiological Society of North America (RSNA).

2 Dec 2009

MRI pioneer honored with MRC Millennium Medal

Sir Peter Mansfield, The University of Nottingham's Nobel Laureate for Physiology and Medicine, is to be recognised, once again, for his part in one of the most important breakthroughs in medical science.

2 Dec 2009

Annual screening ultrasound may benefit women who are at elevated risk for breast cancer

Results of a large-scale clinical trial presented today at the annual meeting of the Radiological Society of North America (RSNA) provide the first strong evidence of the benefit of annual screening ultrasound for women with dense breasts who are at elevated risk for breast cancer. In addition, the study confirmed that MRI is highly sensitive in depicting early breast cancer.

2 Dec 2009

Interactive website to support cancer patients

Millennium: The Takeda Oncology Company today announced the launch of an interactive website in support of the Company’s award-winning global initiative to support patients with cancer.

2 Dec 2009

CRO to run CEL-SCI's upcoming Phase III clinical trial

CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization (CRO) to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate, Multikine®.

1 Dec 2009

ASH to host annual High School Student Symposium at New Orleans Marriott

The American Society of Hematology (ASH) will host its annual High School Student Symposium at the New Orleans Marriott on Thursday, December 3, at 8:00 a.m. CST.

1 Dec 2009

Women's insurance amendment slated for Senate's first health bill vote

As the Senate debates the health reform legislation, amendments are being advanced and Senators are reacting to the bill.

1 Dec 2009

Uninsured cancer patient gives human face to health care debate

The Sacramento Bee has a three-part profile of an uninsured cancer patient, which is tracked alongside the progressing health care reform debate.

1 Dec 2009

Imaging Diagnostic Systems showcases its CTLM system at the 2009 RSNA meeting

Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast imaging, announced today that it is exhibiting its CTLM system and clinical case studies at the 95th annual meeting of the Radiological Society of North America (RSNA) 2009, November 29th – December 3rd in Chicago, Illinois.

1 Dec 2009

Acceleron Pharma announces study results of its ACE-011 and ACE-536 blood forming agents

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

1 Dec 2009

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

1 Dec 2009

Calistoga Pharmaceuticals to present data on its CAL-101 inhibitor at the 51st ASH meeting

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced that clinical and preclinical data supporting the role of CAL-101, an oral, p110δ(delta) selective PI3K inhibitor in patients with hematologic malignancies, will be featured in two oral presentations at the upcoming 51st American Society of Hematology (ASH) Annual Meeting taking place in New Orleans, LA.

1 Dec 2009

Roche's MagNA Pure 96 System for nucleic acid purification evaluated

TriCore Reference Laboratories of Albuquerque, N.M., reported at a recent user meeting results of their research collaboration with Roche Applied Science in which they evaluated Roche´s new MagNA Pure 96 System for use in nucleic acid purification. The evaluation focused on the Roche system’s ability to process specimens for pathogen testing.

1 Dec 2009

Positive results from Ardea Biosciences' ongoing drug-drug interaction study of RDEA594 and febuxostat

Ardea Biosciences, Inc. announced positive results from the first dosing group of an ongoing drug-drug interaction and pharmacodynamic study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen). This

1 Dec 2009

Cancer News and Research

Latest Cancer News and Research

New data on pixantrone Phase III trial in non-Hodgkin's lymphoma to be presented

TGF--1 suppresses the growth of cancer cells, find researchers

Cancer Genomic Microarray Facility selects febit's Geniom RT Analyzer to advance its biomedical research

RapidArc radiotherapy technology delivers highly-precise IMRT treatment

Fight 2 Win PSA launched to find a cure for Hodgkin's Disease

Results from ongoing clinical trial of ISF35 to be presented at ASH annual meeting

Targeted breast ultrasound: A safe and cost effective alternative for women under 40

MRI pioneer honored with MRC Millennium Medal

Annual screening ultrasound may benefit women who are at elevated risk for breast cancer

Interactive website to support cancer patients

CRO to run CEL-SCI's upcoming Phase III clinical trial

ASH to host annual High School Student Symposium at New Orleans Marriott

Women's insurance amendment slated for Senate's first health bill vote

Uninsured cancer patient gives human face to health care debate

Imaging Diagnostic Systems showcases its CTLM system at the 2009 RSNA meeting

Acceleron Pharma announces study results of its ACE-011 and ACE-536 blood forming agents

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Calistoga Pharmaceuticals to present data on its CAL-101 inhibitor at the 51st ASH meeting

Roche's MagNA Pure 96 System for nucleic acid purification evaluated

Positive results from Ardea Biosciences' ongoing drug-drug interaction study of RDEA594 and febuxostat

Cancer Research - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in